Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “BOARD OF REGENTS”

2,639 pharma patents match "BOARD OF REGENTS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,639
Index total 30,257
Page 44 / 110

Quick answer

This filtered view shows 2,639 pharmaceutical patents matching "BOARD OF REGENTS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,639 results for “BOARD OF REGENTS” · 30,257 patents in full index Clear search

  1. US 10226523

    Clostridium difficile vaccine and methods of use

    The Board of Regents of the University of Oklahoma · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted

  2. US 10226521

    Genetically modified Yersinia as vaccines against Yersinia species

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted

  3. US 10226520

    Compositions and methods for enterohemorrhagic Escherichia coli (EHEC) vaccination

    THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXA SYSTEM · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted

  4. US 10221235

    Endotrophin neutralization and use thereof

    The Board of Regents of the University of Texas System · Granted Mar 5, 2019 · Expires Feb 28, 2039

    granted

  5. US 10220078

    Methods of using thrombin derivatives to treat medulloblastoma

    The Board of Regents of the University of Texas System · Granted Mar 5, 2019 · Expires Feb 28, 2039

    granted

  6. US 10219492

    Compounds and methods for altering RSV replication rate

    The Board of Regents of the University of Texas System · Granted Mar 5, 2019 · Expires Feb 28, 2039

    granted

  7. US 10220002

    Controlled-release peptide compositions and uses thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Mar 5, 2019 · Expires Feb 28, 2039

    granted

  8. US 10214529

    Small molecules for the treatment of primary cancer and cancer metastasis

    The Board of Regents of the University of Texas System · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted

  9. US 10213478

    Compositions and methods for the treatment of fungal infections

    Arizona Board of Regents on Behalf of Northern Arizona University · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted

  10. US 10211414

    Phosphorescent tetradentate metal complexes having modified emission spectra

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  11. US 10207013

    Gadolinium-based contrast agents for sensitive detection of Zn2+ with MRI

    The Board of Regents of the University of Texas System · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  12. US 10206904

    Licofelone derivatives and methods of use

    The Board of Regents of the University of Oklahoma · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  13. US 10206903

    Methods of treating muscular dystrophy

    BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE OF THE UNIVERSITY OF NEVADA, RENO · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  14. US 10208012

    Compounds for treating inflammatory and hyperproliferative diseases

    The Board of Regents of the University of Texas System · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  15. US 10208059

    Heterocyclic modulators of HIF activity for treatment of disease

    The Board of Regents of the University of Texas System · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  16. US 10206897

    Creatine ester anti-inflammatory compounds and formulations

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  17. US 10201554

    Esters of 2-deoxy-monosacharides with anti proliferative activity

    The Board of Regents of the University of Texas System · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  18. US 10196450

    Anti-OX40 antibodies and methods of using the same

    The Board of Regents of the University of Texas System · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  19. US 10195297

    Iron garnet nanoparticles for cancer radiotherapy and chemotherapy

    The Board of Regents of the University of Texas System · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  20. US 10188704

    Enhanced melanoma cancer prevention by novel melanotropins

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted

  21. US 10183972

    BK channel-modulating peptides and their use

    The Board of Regents of the University of Texas System · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  22. US 10183055

    Ang-(1-7) derivative oligopeptides for the treatment of pain and other indications

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  23. US 10182997

    Liposomal curcumin for treatment of cancer

    The Board of Regents of the University of Texas System · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  24. US 10183011

    Anti-depression compounds

    The Board of Regents of the University of Texas System · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.